GPBP1

Across TCGA pan-cancer cohorts, GPBP1 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated GPBP1 data layer compared with 21 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher GPBP1 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated GPBP1 expression acts as an unfavorable survival marker, although some lineages such as UCEC and BLCA show a favorable association.

UCEC, SKCM, and LUAD are the cancer types where GPBP1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	II,III,IV	1.000	0.432	.007	32	view →
SKCM	DFS	Median	All	0.158	0.761	<.001	9	view →
LUAD	OS	Median	All	0.250	0.788	.010	6	view →
BLCA	DFS	Median	All	1.000	0.331	.042	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

GPBP1–UCEC (DFS)

Open the UCEC breakdown →